Cell Signaling Technology

HR6A/HR6B Antibody

#4944 · $317

100
Citing papers
10.9k
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation24Circular RNAs in diseases12Cancer-related molecular mechanisms research7Immune cells in cancer6Chronic Lymphocytic Leukemia Research5Extracellular vesicles in disease5Immunotherapy and Immune Responses5Cancer Immunotherapy and Biomarkers4

Papers citing this product

1
Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context
PLoS Biology·2006·1.3k cit.·DOI
2
LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
Nature Communications·2018·518 cit.·DOI
3
MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression
PLoS ONE·2011·494 cit.·DOI
4
Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway
The EMBO Journal·2012·471 cit.·DOI
5
Implications of the tumor immune microenvironment for staging and therapeutics
Modern Pathology·2017·364 cit.·DOI
6
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Stem Cells·2010·317 cit.·DOI
7
Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptor
The Journal of Experimental Medicine·2009·246 cit.·DOI
8
Dynamic recruitment of axin by Dishevelled protein assemblies
Journal of Cell Science·2007·233 cit.·DOI
9
Upregulation of miR‐23a∼27a∼24 decreases transforming growth factor‐beta‐induced tumor‐suppressive activities in human hepatocellular carcinoma cells
International Journal of Cancer·2008·207 cit.·DOI
10
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
Blood·2011·196 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.